Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
MIND Technology
MIND
$45.3M
| $66.4K | ﹤0.01% |
13,034
+3,401
| +35% | +$21.1K |
|
|
TMBR
4352
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $66.3K | ﹤0.01% |
22,292
+2,493
| +13% | +$5.81K |
|
|
NVVE
4353
DELISTED
Nuvve Holding Corp
NVVE
| $66.2K | ﹤0.01% |
+1
| New | +$152K |
|
|
MTVA
4354
MetaVia Inc
MTVA
$7.33M
| $66K | ﹤0.01% |
+1,576
| New | +$70.2K |
|
4355
PodcastOne
PODC
$102M
| $65.9K | ﹤0.01% |
+33,268
| New | +$82.5K |
|
|
SSKN
4356
DELISTED
Strata Skin Sciences
SSKN
| $65.8K | ﹤0.01% |
11,062
+7,002
| +172% | +$53.8K |
|
|
EZGO
4357
EZGO Technologies
EZGO
$2.09M
| $65.5K | ﹤0.01% |
+3
| New | +$706K |
|
|
AFMD
4358
DELISTED
Affimed
AFMD
| $65K | ﹤0.01% |
13,595
| – | – |
|
|
QXO
4359
QXO Inc
QXO
$13.8B
| $64.9K | ﹤0.01% |
2,436
+3
| +0.1% | +$84 |
|
|
CWBR
4360
DELISTED
CohBar, Inc. Common Stock
CWBR
| $64.9K | ﹤0.01% |
20,934
+5,791
| +38% | +$17.1K |
|
|
TLIS
4361
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $64.9K | ﹤0.01% |
11,280
+1,911
| +20% | +$13.1K |
|
|
SALM
4362
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $64.6K | ﹤0.01% |
109,460
-18,292
| -14% | -$14.1K |
|
4363
Imunon
IMNN
$6.68M
| $64.5K | ﹤0.01% |
5,106
+1,355
| +36% | +$21.2K |
|
|
MAAS
4364
Maase Inc
MAAS
$7.87B
| $64.4K | ﹤0.01% |
205
| – | – |
|
|
UPH
4365
DELISTED
UpHealth, Inc.
UPH
| $64.3K | ﹤0.01% |
65,656
+15,980
| +32% | +$23.3K |
|
4366
Edesa Biotech
EDSA
$49.2M
| $64.3K | ﹤0.01% |
14,684
+2,299
| +19% | +$13.6K |
|
4367
Moving iMage Technologies
MITQ
$5.27M
| $63.8K | ﹤0.01% |
73,369
-7,980
| -10% | -$7.62K |
|
4368
NexGel
NXGL
$3.83M
| $63.6K | ﹤0.01% |
30,274
-8,587
| -22% | -$18.7K |
|
|
SGRP
4369
DELISTED
SPAR Group
SGRP
| $63.2K | ﹤0.01% |
65,617
-19,349
| -23% | -$22.2K |
|
|
BCLI
4370
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $62.2K | ﹤0.01% |
20,718
+2,338
| +13% | +$53.2K |
|
4371
BioCardia
BCDA
$12.3M
| $62K | ﹤0.01% |
9,677
| – | – |
|
4372
Direct Digital Holdings
DRCT
$1.89M
| $61.5K | ﹤0.01% |
109
-12
| -10% | -$6.71K |
|
|
ATHX
4373
DELISTED
Athersys, Inc. Common Stock
ATHX
| $61.4K | ﹤0.01% |
141,978
-13,319
| -9% | -$7.28K |
|
|
VEV
4374
DELISTED
Vicinity Motor Corp. Common Stock
VEV
| $60.8K | ﹤0.01% |
64,732
| – | – |
|
4375
Pasithea Therapeutics
KTTA
$15.4M
| $60.1K | ﹤0.01% |
6,256
+1,344
| +27% | +$14.7K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.